Sorafenib Accord 欧州連合 - アイスランド語 - EMA (European Medicines Agency)

sorafenib accord

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - Æxlishemjandi lyf - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

Lyngonia (Alleviate) Filmuhúðuð tafla 425,25-519,75 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

lyngonia (alleviate) filmuhúðuð tafla 425,25-519,75 mg

florealis ehf. - dry bearberry leaf extract (der 2.5 - 4.5:1) - filmuhúðuð tafla - 425,25-519,75 mg

CitraFleet Mixtúruduft, lausn í skammtapoka 10,0 mg/3,5 g/10,97 g アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

citrafleet mixtúruduft, lausn í skammtapoka 10,0 mg/3,5 g/10,97 g

casen recordati s.l. - natrii picosulfas inn; magnesii oxidum; citric acid - mixtúruduft, lausn í skammtapoka - 10,0 mg/3,5 g/10,97 g

Duta Tamsaxiro Hart hylki 0,5/0,4 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

duta tamsaxiro hart hylki 0,5/0,4 mg

medical valley invest ab - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg

Duodart Hart hylki 0,5/0,4 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

duodart hart hylki 0,5/0,4 mg

glaxosmithkline pharma a/s - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg

Dutaprostam Hart hylki 0,5/0,4 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

dutaprostam hart hylki 0,5/0,4 mg

zentiva k.s.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg